NASDAQ:INOV Inovalon (INOV) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free INOV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$27.78▼$27.7850-Day Range$40.66▼$41.0652-Week Range$17.56▼$41.06Volume1 shsAverage Volume720,587 shsMarket Capitalization$4.31 billionP/E Ratio81.71Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesInsider TradesOwnershipSocial MediaSustainabilityStock AnalysisCompetitorsHeadlinesInsider TradesOwnershipSocial MediaSustainability Get Inovalon alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Inovalon Stock (NASDAQ:INOV)Inovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded in 1998 and is headquartered in Bowie, MD.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> INOV Stock News HeadlinesApril 24, 2024 | forbes.comThree Lessons From The Cloud Revolution That Will Transform HealthcareApril 16, 2024 | finance.yahoo.comFountainRx Selects Inovalon’s ScriptMed® Software To Enhance Patient Care and Scale Specialty and Infusion Pharmacy ServicesApril 28, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 5, 2024 | bizjournals.comMaryland's 10 billionaires ranked by net worth, according to ForbesMarch 18, 2024 | finance.yahoo.comInovalon Announces Converged Submissions To Support Health Plan Risk Adjustment ProgramsMarch 5, 2024 | forbes.comThe Role Of Data At Every Step Of The Healthcare JourneyFebruary 21, 2024 | finance.yahoo.comInovalon's VigiLanz Solution Ranked No. 1 by KLAS Research in Pharmacy Surveillance and Infection Control and MonitoringFebruary 15, 2024 | msn.comGlobal Payments Earnings Transcript (NYSE:GPN)April 28, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 7, 2024 | fortune.comExclusive: What Andreessen Horowitz’s Anish Acharya is looking for in consumer AI startupsFebruary 6, 2024 | msn.comInovalon buys clinical surveillance platform provider VigiLanzJanuary 24, 2024 | finance.yahoo.comClearsense Appoints Jason Rose as New Chief Executive Officer and Board MemberJanuary 22, 2024 | finance.yahoo.comPalmetto Pharm Selects Inovalon ScriptMed® To Improve Patient Outcomes and Streamline OperationsJanuary 11, 2024 | finance.yahoo.comNLP in Healthcare & Life Sciences Market worth $11.8 billion by 2028, growing at a CAGR of 34.4%: Report by MarketsandMarkets™January 9, 2024 | finance.yahoo.comMichael Hasbany, Former Inovalon Executive, Joins Healthmine’s Advisory BoardJanuary 8, 2024 | msn.com2024 calendar dates: Easter, MLK Day, Thanksgiving and other key holiday dates to rememberJanuary 4, 2024 | msn.comEaster, MLK Day, Thanksgiving and other key dates to know for 2024 calendarDecember 11, 2023 | finance.yahoo.comInovalon Applauded by Frost & Sullivan for Improving Healthcare Delivery, Patient Outcomes, and Data Security with Its Inovalon ONE® PlatformDecember 8, 2023 | finance.yahoo.comNatural Language Processing (NLP) in Healthcare and Life Sciences Market to Hit $32.14 Billion by 2030: Coherent Market InsightsNovember 30, 2023 | benzinga.comNLP in Healthcare & Life Sciences Market worth $11.8 billion by 2028 - Exclusive Report by MarketsandMarkets™November 20, 2023 | finance.yahoo.comInovalon Introduces First-Ever Solution to Provide Health Plans Current Marketplace Quality Benchmarking Data MonthlyNovember 7, 2023 | tmcnet.comHiLabs Grows Product Delivery Leadership With Sumeet Seth and Harsh VardhanNovember 7, 2023 | finance.yahoo.comInovalon Expands Schedule Management SaaS Solution to Include Management of Third-Party Agency StaffNovember 2, 2023 | uk.finance.yahoo.comQ3 2023 G1 Therapeutics Inc Earnings CallOctober 30, 2023 | finance.yahoo.comInovalon Customers Achieve Higher Performance on CMS Medicare Advantage Health Plan RatingsOctober 26, 2023 | benzinga.comHealthcare IT Integration Market Is Anticipated To Amplify At A CAGR Of 12.4% Over 2023-2033 | We Market ResearchOctober 24, 2023 | benzinga.comPortnoy Law Investigates Enhanced Compensation for EngageSmart, Inc. Shareholders - ESMTSee More Headlines Receive INOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inovalon and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/28/2021Today4/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Data Processing & Preparation Sub-IndustryN/A Current SymbolNASDAQ:INOV CUSIPN/A CIK1619954 Webwww.inovalon.com Phone(301) 809-4000Fax301-809-8060Employees1,836Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.34 Trailing P/E Ratio81.71 Forward P/E Ratio46.30 P/E Growth2.99Net Income$22.58 million Net Margins6.73% Pretax Margin5.86% Return on Equity10.97% Return on Assets4.10% Debt Debt-to-Equity Ratio1.17 Current Ratio2.40 Quick Ratio2.40 Sales & Book Value Annual Sales$667.52 million Price / Sales6.46 Cash Flow$0.83 per share Price / Cash Flow33.35 Book Value$4.94 per share Price / Book5.62Miscellaneous Outstanding Shares155,246,000Free Float78,011,000Market Cap$4.31 billion OptionableNo Data Beta0.53 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesKeith R. DunleavyChairman & Chief Executive OfficerEron S. KellyPresidentJonathan R. BoldtChief Financial & Accounting OfficerPaige C. KilianChief Medical OfficerMonica KeenethChief Information Security Officer & VPKey CompetitorsFive9NASDAQ:FIVNDXC TechnologyNYSE:DXCPerspectaNYSE:PRSPBilibiliNASDAQ:BILIClarivateNYSE:CLVTView All CompetitorsInstitutional OwnershipDHJJ Financial Advisors Ltd.Bought 2,160 shares on 4/11/2024Ownership: 0.001%Advisory Services Network LLCBought 9,738 shares on 2/9/2024Ownership: 0.006%Arlington Capital Management Inc.Bought 7,480 shares on 2/7/2024Ownership: 0.005%Corrado Advisors LLCBought 15,615 shares on 2/1/2024Ownership: 0.010%View All Institutional Transactions INOV Stock Analysis - Frequently Asked Questions How were Inovalon's earnings last quarter? Inovalon Holdings, Inc. (NASDAQ:INOV) released its quarterly earnings results on Wednesday, July, 28th. The technology company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.02. The technology company earned $190.44 million during the quarter, compared to the consensus estimate of $183.89 million. Inovalon had a trailing twelve-month return on equity of 10.97% and a net margin of 6.73%. What is Keith R. Dunleavy's approval rating as Inovalon's CEO? 410 employees have rated Inovalon Chief Executive Officer Keith R. Dunleavy on Glassdoor.com. Keith R. Dunleavy has an approval rating of 57% among the company's employees. This puts Keith R. Dunleavy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Inovalon own? Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), DexCom (DXCM), NVIDIA (NVDA), Digital Turbine (APPS), PayPal (PYPL), Block (SQ), Taiwan Semiconductor Manufacturing (TSM) and Enphase Energy (ENPH). When did Inovalon IPO? Inovalon (INOV) raised $500 million in an initial public offering (IPO) on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers. Who are Inovalon's major shareholders? Inovalon's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include DHJJ Financial Advisors Ltd. (0.00%). View institutional ownership trends. This page (NASDAQ:INOV) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovalon Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
